NIH Exploratory/Developmental Clinical Research Grants in Obesity (R21)

This opportunity encourages research grant applications from institutions/organizations that propose to conduct exploratory/developmental clinical studies that will accelerate the development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children. Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program.


The project period is up to 2 years and the budget is $275,000.  There will be regular deadlines until 8 May 2015.  The next deadlines are 16 June 2012 and 16 October 2012. 


For more information please see: http://grants.nih.gov/grants/guide/pa-files/PA-12-179.html

NIH Multidisciplinary Studies of HIV/AIDS and Aging (R01, R21, or R03))

This opportunity invites applications proposing to study HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.  


There are three mechanisms through which you can apply for this grant:
R01: up to 5 years support, budget unlimited (see http://grants.nih.gov/grants/guide/pa-files/PAR-12-175.html)
R21: up to 2 years, $275,000 budget (see http://grants.nih.gov/grants/guide/pa-files/PAR-12-174.html)
R03: up to 2 years, $100,000 budget (see http://grants.nih.gov/grants/guide/pa-files/PAR-12-176.html)


There will be regular deadlines for this grant until April 2015.  The next deadline is 7 August 2012.

NIH Basic Research on HIV Persistence (R01 or R21)

The purpose of this Funding Opportunity Announcement (FOA) is to increase our understanding of persistent HIV-1 infection in patients under highly active anti-retroviral therapy (HAART). Support would be through soliciting applications for hypothesis-driven basic research in HIV/AIDS that is focused on directly achieving this aim. The emphasis of this initiative is on the development of new ideas and approaches in HIV-1 persistence including model and assay development that may directly inform future studies on the design of therapeutic strategies to achieve long term remission without treatment or a complete eradication of residual virus and complete cure for HIV infection and AIDS.

There are two mechanisms to available to apply for this grant:

R01 (budget not limited, project period up to 5 years; see http://grants.nih.gov/grants/guide/pa-files/PA-12-161.html)

R21 (budget $275,000, project period of 2 years; see http://grants.nih.gov/grants/guide/pa-files/PA-12-162.html)

This opportunity will have regular deadlines until January 2015.  The next deadline is 7 September 2012.

Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R01)

This grant opportunity encourages interdisciplinary research aimed at promoting health, limiting symptoms and disease, and reducing health disparities in children and older adults living or spending time in non-traditional settings. These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases including lower respiratory diseases, chronic obstructive pulmonary disease, and cardiovascular diseases. Risk identification and symptom management include prevention and behavior changes and actions to maintain health and prevent disease with an emphasis on the individual, family, and community which will advance nursing science. 


For purposes of this FOA, non-traditional settings, for children and older adults, include, but are not limited to places such as community centers, pre-school and non-traditional school environments (e.g., churches, daycare, home-based schools, dormitories, and alternative schools), child and older adult foster care facilities, older adult day care facilities, half-way homes,  assisted living and long-term care facilities.    


Budget: Not limited (but must reflect actual needs), 5 year project period.
Deadlines: 5 June 2012, 5 October 2012, and more


For more information, see: http://grants.nih.gov/grants/guide/pa-files/PA-12-133.html

NIH Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01)

This grant seeks applications to test the utility and implementation of technological tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services.


Budget: Not limited (must reflect actual needs) over 5 years.
Deadlines: 7 May 2012, 7 September 2012, and more.


See http://grants.nih.gov/grants/guide/pa-files/PA-12-117.html for more details.

MARIE CURIE INTERNATIONAL INCOMING FELLOWSHIPS (IIF)

MARIE CURIE INTERNATIONAL INCOMING FELLOWSHIPS (IIF) Identifier: FP7-PEOPLE-2012-IIF

International Incoming Fellowships are designed to give researchers from outside of Europe an opportunity to work on research projects in Europe. This helps to develop research cooperation between Europe and other parts of the world to everybody’s benefit.

International Incoming Fellowships are directed exclusively at experienced researchers, namely those who either:

1.    have at least 4 years of research experience (full-time equivalent) after obtaining the degree which would formally entitle them to embark on a doctorate either in the country in which the degree was obtained or in the country in which the research will be carried out; or

2.    are already in possession of a doctoral degree (PhD).

All Marie Curie Actions have a bottom-up approach, i.e. all fields of research of interest to the European Union are eligible for funding. All research carried out must respect fundamental ethics principles (see also the Ethics part of the Guide for Applicants).

The time limit to fulfill one of these conditions is the deadline for proposal submission of the relevant call.

The required research experience does not include breaks during the research career.

Deadline:  16 August 2012 at 17:00:00 (Brussels local time)

Budget: € 40 000 000

For further information, see: http://ec.europa.eu/research/participants/portal/page/people?callIdentifier=FP7-PEOPLE-2012-IIF

NIH Partnerships for Interventions to Treat Chronic, Persistent and Latent Infections (R21/R33)

This grant opportunity seeks to stimulate basic and early-stage translational research focused on development of novel intervention strategies to clear persistent, chronic or latent infectious agents from the host. Responsive applications will define and address a therapeutic need specific to a targeted pathogen.    

Examples of possible intervention strategies include, but are not limited to:

• Targeting pathogen latency establishment and/or maintenance mechanisms;
• Targeting mechanisms enabling pathogen evasion of host immune responses;
• Enhancing pathogen susceptibility to existing interventions;
• Modulation of pathogen-specific immune cells;
• Restoration and/or enhancement of specific aspects of the immune system
• Targeting of specific metabolic sub-populations responsible for chronic infections
• Eliminating replication competent viral nucleic acids from infected cells

The grant is worth $275,000 for the first two years, and then an additional $300,000 per year for three years for a total of $1,175,000.

A letter of intent must be submitted by June 13, 2012.  The full application should be submitted by July 13, 2012.

For more information, see http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-020.html